RANI
Rani Therapeutics Holdings Inc
0.8108$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 8.3% | – | – | – | 25.9% | – | – | – | 12.7% | 9.4% | – | – | |
| – | 91.7% | – | – | – | 100.0% | 100.0% | – | – | 100.0% | 90.6% | 100.0% | 92.1% | |
| – | 276.6% | – | – | – | 662.5% | 3,819.8% | – | – | 336.0% | 302.2% | 293.7% | 375.4% | |
| – | 211.9% | – | – | – | 531.3% | 3,264.5% | – | – | 348.2% | 286.1% | 323.1% | 400.4% | |
| – | 488.5% | – | – | – | 1,555.1% | 7,084.3% | – | – | 684.2% | 578.8% | 616.9% | 772.5% | |
| – | -488.5% | – | – | – | -1,455.1% | -6,984.3% | – | – | -584.2% | -488.2% | -516.9% | -675.8% | |
| – | 47.1% | – | – | – | 109.3% | 548.3% | – | – | 23.8% | 5.2% | 0.5% | 23.9% | |
| – | -511.1% | – | – | – | -1,529.4% | -7,405.8% | – | – | -621.1% | -469.3% | -493.0% | -685.3% | |
| – | -253.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -258.1% | – | – | – | -870.3% | -4,223.3% | – | – | -705.3% | -411.8% | -432.7% | -618.0% | |
| – | -455.7% | – | – | – | -1,394.2% | -6,711.6% | – | – | -584.6% | -454.7% | -516.9% | -658.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.